Comparison Between 2 Doses of Misoprostol Before Intrauterine Device
NCT ID: NCT02901561
Last Updated: 2017-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
212 participants
INTERVENTIONAL
2016-09-30
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion
NCT04273984
Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion
NCT03790371
Misoprostol for Cervical Priming Before Office Hysteroscopy
NCT03276000
Optimal Timing of Misoprostol Administration Prior to Office Hysteroscopy
NCT02316301
Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery
NCT04080349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
misoprostol 200
misoprostol 200 microgram placed into the vagina 3 hours prior to having the intrauterine device inserted
misoprostol 200
misoprostol 400
misoprostol 400 microgram placed into the vagina 3 hours prior to having the intrauterine device inserted
misoprostol 400
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
misoprostol 200
misoprostol 400
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who will accept to participate in the study
Exclusion Criteria
20 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MISO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.